IRIS
DI BENEDETTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.059
AS - Asia 2.232
EU - Europa 2.079
SA - Sud America 205
AF - Africa 36
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.991
SG - Singapore 970
IE - Irlanda 535
CN - Cina 492
RU - Federazione Russa 439
SE - Svezia 224
HK - Hong Kong 212
VN - Vietnam 208
IT - Italia 200
TR - Turchia 198
BR - Brasile 181
DE - Germania 174
UA - Ucraina 131
GB - Regno Unito 119
FR - Francia 81
FI - Finlandia 61
IN - India 49
CA - Canada 44
NL - Olanda 31
BE - Belgio 28
JP - Giappone 21
MX - Messico 13
BD - Bangladesh 12
ID - Indonesia 11
PL - Polonia 11
ZA - Sudafrica 11
ES - Italia 9
IQ - Iraq 9
AR - Argentina 8
CZ - Repubblica Ceca 8
EC - Ecuador 7
KR - Corea 6
DZ - Algeria 5
LT - Lituania 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
AU - Australia 4
JM - Giamaica 4
LB - Libano 4
PK - Pakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
JO - Giordania 3
KW - Kuwait 3
MA - Marocco 3
MK - Macedonia 3
MY - Malesia 3
PH - Filippine 3
CI - Costa d'Avorio 2
CO - Colombia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.622
Salva come PNG Salva come JPEG
Città #
Chandler 603
Dublin 535
Jacksonville 530
Singapore 522
San Jose 403
Ashburn 266
Dallas 217
Hong Kong 208
Santa Clara 182
Boardman 148
Izmir 137
Council Bluffs 130
New York 117
The Dalles 103
Beijing 99
Ann Arbor 95
L'aquila 82
Nanjing 80
Lawrence 75
Moscow 75
Princeton 75
Ho Chi Minh City 66
Wilmington 64
Los Angeles 60
San Mateo 44
Dearborn 42
Hanoi 41
Woodbridge 35
Nanchang 31
Amsterdam 29
Dong Ket 26
L’Aquila 26
Columbus 25
Lauterbourg 25
Milan 25
Brussels 24
Munich 24
Helsinki 22
São Paulo 22
Hefei 21
Shanghai 21
Tokyo 21
Verona 19
Seattle 17
Kunming 16
Mountain View 16
Orem 16
Shenyang 16
Jiaxing 14
Montreal 14
Chennai 13
Des Moines 12
Haiphong 12
Houston 12
Frankfurt am Main 11
Hebei 11
Tianjin 11
Zhengzhou 11
Chicago 10
Johannesburg 10
Pune 10
San Francisco 10
Warsaw 10
Changsha 9
Ningbo 9
Stockholm 9
Grafing 8
Jinan 8
Norwalk 8
Guangzhou 7
Jakarta 7
Mumbai 7
Phoenix 7
Poplar 7
Rome 7
Atlanta 6
Brno 6
London 6
Manchester 6
Rio de Janeiro 6
Toronto 6
Bremen 5
Denver 5
Edinburgh 5
Hangzhou 5
Lanzhou 5
Nuremberg 5
Pescara 5
Ankara 4
Brasília 4
Brooklyn 4
Da Nang 4
Erbil 4
Falkenstein 4
Fremont 4
Leuven 4
Madrid 4
Mexico City 4
Miami 4
New Delhi 4
Totale 5.859
Salva come PNG Salva come JPEG
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 181
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 158
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 157
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 155
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 154
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 153
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 151
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 151
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 150
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 148
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 143
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 142
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 141
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 138
Cardiovascular disease in primary sjögren’s syndrome 136
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 136
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 135
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 133
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 132
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 131
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 130
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 128
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 126
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 125
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 125
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 124
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 123
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 122
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 121
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 120
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 120
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 119
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 118
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 117
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 117
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 117
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 116
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 115
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 114
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 113
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 111
Interstitial lung disease in systemic sclerosis: current and future treatment. 111
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 110
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 110
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 109
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 109
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 108
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 108
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 107
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 107
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 107
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 107
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 107
The Vessels Contribute to Fibrosis in Systemic Sclerosis 106
Cellular players in angiogenesis during the course of systemic sclerosis. 103
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 102
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 101
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 100
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis 99
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 98
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 97
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives 92
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 91
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 91
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 90
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 90
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 90
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 88
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 87
Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2 87
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 80
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 80
Potential of stem cells in the treatment of rheumatic disease 79
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor 70
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 68
Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis 68
Totale 8.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022457 25 16 97 38 11 10 4 24 33 38 37 124
2022/20231.580 113 115 29 199 108 166 2 95 675 12 46 20
2023/2024377 60 21 21 29 35 132 9 16 1 15 4 34
2024/20251.492 38 28 146 56 230 121 165 92 330 69 119 98
2025/20262.797 198 260 143 313 282 208 472 92 255 360 186 28
Totale 8.803